Merck Canada Commits $4M to Life Sciences Commercialization
Merck Canada is providing $4 million in financing to the Institute for Research in Immunology and Cancer – Commercialization of Research, a non-profit organization with a mandate to accelerate the discovery, development and commercialization of novel drugs in oncology, immunology and related indications that originate from the Université de Montréal.
29 April 2013•6 mins read
